GLP-1 Receptor Agonist Prescriptions for Adolescents With Obesity and Associated Disparities

Key Points

• The study aims to analyze the patterns of GLP-1 receptor agonist prescriptions among adolescents with obesity and identify any associated disparities.
• Examined prescribing patterns of GLP-1 receptor agonists in a population of adolescents.
• Identified demographic factors contributing to disparities in prescriptions.
• Disparities in the prescription of GLP-1 receptor agonists were observed among different demographic groups.
• Findings indicate that not all adolescents with obesity receive equal access to GLP-1 therapies.